Labs as a safety instrument
For several peptides — especially those that interact with the growth-hormone axis or with metabolism — a provider may want baseline labs before prescribing and follow-up labs afterward. The baseline establishes your starting point; the follow-up shows how your body is responding and flags anything that warrants a change.
For growth-hormone-axis peptides, for example, a provider may look at markers like IGF-1 alongside metabolic measures such as fasting glucose, because that's where early signals of a problem would tend to appear. The exact panel depends on the peptide and on you.
Which peptides involve labs
Not every peptide requires lab work. Each peptide's profile notes whether baseline labs are typically expected, so you know what's involved before you start. When labs are part of the plan, your provider orders the specific, relevant panel — you don't have to assemble it yourself or guess at which tests matter.
Lab-guided, not bureaucratic
Labs exist to inform the conversation between you and your provider — to make care safer and more tailored, not to generate busywork or upsells. If a result suggests a peptide isn't serving you, that's exactly the kind of thing the monitoring is there to catch, and it's a reason to adjust or stop.
Used well, lab work turns peptide therapy from a guess into something you can actually steer.